Martin E Gleave Selected Research

Carcinogenesis

3/2014	Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.
1/2009	In vivo knockdown of the androgen receptor results in growth inhibition and regression of well-established, castration-resistant prostate tumors.
9/2004	Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin E Gleave Research Topics

Disease

187	Prostatic Neoplasms (Prostate Cancer) 04/2024 - 02/2002
151	Neoplasms (Cancer) 01/2024 - 05/2002
19	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 06/2004
17	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2002
14	Adenocarcinoma 04/2024 - 05/2012
7	Disease Progression 01/2022 - 06/2009
6	Carcinoma (Carcinomatosis) 01/2024 - 01/2016
6	Reperfusion Injury 01/2022 - 03/2010
6	Renal Cell Carcinoma (Grawitz Tumor) 01/2020 - 05/2002
4	Inflammation (Inflammations) 01/2021 - 03/2012
4	Non-Muscle Invasive Bladder Neoplasms 05/2011 - 06/2008
3	Residual Neoplasm 09/2023 - 05/2017
3	Hypoxia (Hypoxemia) 01/2021 - 11/2015
3	Margins of Excision 11/2016 - 09/2012
3	Carcinogenesis 03/2014 - 09/2004
3	Breast Neoplasms (Breast Cancer) 01/2010 - 08/2005
2	Melanoma (Melanoma, Malignant) 12/2019 - 06/2005
2	Extranodal Extension 11/2016 - 06/2015
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2015 - 03/2012

Drug/Important Bio-Agent (IBA)

75	AndrogensIBA 12/2023 - 02/2002
61	Androgen Receptors (Androgen Receptor)IBA 01/2024 - 06/2004
46	Proteins (Proteins, Gene)FDA Link 12/2023 - 10/2002
43	ClusterinIBA 01/2022 - 02/2002
31	Hormones (Hormone)IBA 01/2021 - 02/2002
25	Antisense OligonucleotidesIBA 10/2020 - 05/2002
20	Prostate-Specific Antigen (Semenogelase)IBA 01/2024 - 07/2003
17	Biomarkers (Surrogate Marker)IBA 01/2024 - 02/2010
16	enzalutamideIBA 01/2021 - 01/2015
15	Docetaxel (Taxotere)FDA Link 09/2023 - 09/2005
13	Messenger RNA (mRNA)IBA 09/2023 - 07/2003
12	Transcription Factors (Transcription Factor)IBA 04/2024 - 09/2008
10	DNA (Deoxyribonucleic Acid)IBA 09/2023 - 07/2012
10	OGX-011IBA 03/2012 - 08/2005
10	Paclitaxel (Taxol)FDA LinkGeneric 12/2011 - 03/2004
8	Phosphotransferases (Kinase)IBA 11/2021 - 06/2004
8	Small Interfering RNA (siRNA)IBA 10/2015 - 03/2004
8	OligonucleotidesIBA 11/2011 - 02/2002
8	OligodeoxyribonucleotidesIBA 01/2007 - 06/2004
7	RNA (Ribonucleic Acid)IBA 01/2024 - 11/2011
7	EnzymesIBA 12/2023 - 03/2004
7	SteroidsIBA 01/2021 - 08/2008
7	Testosterone (Sustanon)FDA Link 10/2019 - 05/2007
6	apatorsenIBA 01/2018 - 08/2008
5	Semaphorins (Semaphorin)IBA 01/2024 - 01/2017
5	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024 - 07/2003
5	LigandsIBA 03/2021 - 10/2013
5	Cell-Free Nucleic AcidsIBA 12/2020 - 05/2015
5	Circulating Tumor DNAIBA 01/2020 - 12/2017
5	PlatinumIBA 11/2019 - 03/2012
5	abirateroneIBA 01/2019 - 01/2015
5	Androgen Antagonists (Antiandrogens)IBA 10/2017 - 08/2008
5	Insulin-Like Growth Factor I (IGF-1)IBA 03/2014 - 07/2003
4	Prednisone (Sone)FDA LinkGeneric 12/2019 - 09/2010
4	Glucose (Dextrose)FDA LinkGeneric 07/2018 - 10/2015
4	Cisplatin (Platino)FDA LinkGeneric 04/2018 - 02/2005
4	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2016 - 08/2008
4	Glycoproteins (Glycoprotein)IBA 06/2015 - 03/2004
4	Insulin-Like PeptidesIBA 12/2014 - 06/2006
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 11/2013 - 12/2004
4	Insulin (Novolin)FDA Link 09/2011 - 01/2009
4	AntibodiesIBA 01/2009 - 06/2004
3	Ointments (Pastes)IBA 01/2021 - 09/2005
3	Abiraterone AcetateIBA 12/2019 - 05/2015
3	Lactic Acid (Lactate)FDA LinkGeneric 07/2018 - 01/2016
3	bicalutamide (Casodex)FDA LinkGeneric 01/2018 - 06/2012
3	HSP27 Heat-Shock ProteinsIBA 01/2018 - 07/2014
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2016 - 07/2010
3	Complementary DNA (cDNA)IBA 12/2016 - 05/2002
3	capivasertibIBA 06/2015 - 02/2013
3	Levodopa (L Dopa)FDA LinkGeneric 06/2012 - 01/2007
3	Carboxy-LyasesIBA 06/2012 - 01/2007
3	Gemcitabine FDA Link 03/2012 - 06/2004
3	HTI-286IBA 08/2009 - 03/2008
3	CholesterolIBA 07/2009 - 03/2004
2	Interleukin-33IBA 01/2024 - 01/2016
2	darolutamideIBA 06/2021 - 01/2018
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 12/2020 - 02/2013
2	Protein Isoforms (Isoforms)IBA 10/2020 - 01/2007
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2020 - 08/2015
2	Leuprolide (Lupron)FDA LinkGeneric 10/2019 - 05/2017
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 10/2019 - 05/2017
2	tyrosine receptor (receptor, tyrosine)IBA 12/2018 - 01/2018
2	Vitamin D FDA LinkGeneric 04/2018 - 08/2005
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2017 - 02/2017
2	Sunitinib (Sutent)FDA Link 11/2015 - 10/2015
2	Cadherins (E-Cadherin)IBA 04/2015 - 02/2012
2	integrin-linked kinaseIBA 04/2015 - 02/2012
2	GlucocorticoidsIBA 02/2015 - 01/2007
2	Insulin ReceptorIBA 12/2014 - 01/2009
2	SNX-5422IBA 07/2014 - 04/2011

Therapy/Procedure

92	Therapeutics 12/2023 - 02/2002
82	Castration 01/2024 - 07/2003
24	Prostatectomy (Retropubic Prostatectomy) 04/2024 - 09/2002
17	Drug Therapy (Chemotherapy) 10/2020 - 03/2003
9	Radiotherapy 04/2024 - 10/2002
8	Intravesical Administration 01/2021 - 06/2004
4	Aftercare (After-Treatment) 01/2018 - 12/2003
3	Immunotherapy 01/2024 - 11/2019
3	Neoadjuvant Therapy 09/2023 - 05/2017
3	Precision Medicine 12/2015 - 08/2014